T-DXd

trastuzumab deruxtecan · AstraZeneca and Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-DXd, covering 2025-10-24 to 2025-10-24. Get the full timeline:

Most recent: Clinical Trial Update: TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd [Phase 2]